REG - Polar Cap Glb Health PCGH ZDP PLC - Result of AGM

Polar Capital Global Healthcare TrustAnnouncement

26/02/2026 16:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260226:nRSZ5931Ua&default-theme=true

RNS Number : 5931U  Polar Capital Global Health Tst PLC  26 February 2026

Polar Capital Global Healthcare Trust plc ("the Company")

Legal Entity Identifier: 549300YV7J2TWLE7PV84

 

Results of the Company's 15(th) Annual General Meeting ("AGM")

held at 2:00pm on Thursday 26 February 2026

 

All the resolutions proposed at the Annual General Meeting of the Company were
voted on and passed on a poll. The resolutions proposed at the AGM can be
found in the Notice of AGM which is available on the Company's website.

The following table indicates the number of poll votes received for each of
the resolutions. It should be noted that votes withheld do not
constitute votes in law. As at the date of the AGM, the Company's issued
share capital consisted of 124,149,256 Ordinary shares of 25p each. The
Company holds 25,754,256 Ordinary shares in treasury. Therefore, the total
voting rights in the Company is 98,395,000; 40% of the voting rights were cast
by proxy.

In accordance with Listing Rule 6.4.2, copies of resolutions 14 to 16 (having
been passed as special resolutions), will be submitted to the National Storage
Mechanism and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 Resolution                                                                     In favour   Against    Withheld
 1.    To receive and consider the Annual Report and Financial Statements       40,011,212  18,189     24,417
 for the year ended 30 September 2025.

 2.    To approve the Directors' Remuneration Policy.                           39,967,772  49,372     36,674

 3.    To approve the Directors' Remuneration Implementation Report for the     39,956,837  54,851     42,130
 year ended 30 September 2025.

 4.    To re-elect Lisa Arnold as a Director.                                   39,012,966  1,018,462  22,390

 5.    To re-elect Neal Ransome as a Director.                                  39,457,403  568,048    28,367

 6.    To elect Caroline Gulliver as a Director.                                39,992,139  16,712     44,967

 7.    To elect Stacey Parrinder-Johnson as a Director.                         39,986,133  22,718     44,967

 8.    To re-elect Jeremy Whitley as a Director.                                39,452,174  568,189    33,455

 9.    To re-appoint PricewaterhouseCoopers LLP as auditors.                    39,974,911  56,509     22,398

 10.  To authorise the Directors to determine the auditors' remuneration.       40,021,770  7,391      24,657

 11.  To approve the Company's Dividend Policy.                                 40,035,753  3,854      14,211

 12.  To authorise the allotment of ordinary shares - First Authority.          40,022,721  16,433     14,664

 13.  To authorise the allotment of ordinary shares - Second Authority.         39,978,772  52,527     22,519

 14.  To disapply pre-emption rights - First Authority.                         39,938,516  91,533     23,769

 15.  To disapply pre-emption rights - Second Authority.                        39,879,803  150,246    23,769

 16.  To grant the Company authority to buy back its own ordinary shares.       39,769,459  265,060    19,299

 

 

Enquiries:

Tracey Lago, FCG

Polar Capital Global Healthcare Trust plc

020 7227 2700

https://www.polarcapitalglobalhealthcaretrust.co.uk/
(https://www.polarcapitalglobalhealthcaretrust.co.uk/)

 

26 February 2026

 

 

Neither the contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other website) is
incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSEFFMMEMSEEE



            Copyright 2019 Regulatory News Service, all rights reserved